These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 17493308

  • 1. Resource use and costs associated with different states of breast cancer.
    Lidgren M, Wilking N, Jönsson B, Rehnberg C.
    Int J Technol Assess Health Care; 2007; 23(2):223-31. PubMed ID: 17493308
    [Abstract] [Full Text] [Related]

  • 2. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O, Alvegård T, Conradi N, Lenhoff S, Mellqvist UH, Persson U, Löthgren M.
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [Abstract] [Full Text] [Related]

  • 3. Resource use and costs in a Swedish cohort of patients with Parkinson's disease.
    Hagell P, Nordling S, Reimer J, Grabowski M, Persson U.
    Mov Disord; 2002 Nov; 17(6):1213-20. PubMed ID: 12465059
    [Abstract] [Full Text] [Related]

  • 4. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM, Shim B, Goodman S, Amonkar MM.
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [Abstract] [Full Text] [Related]

  • 5. Cost of radiotherapy in Sweden.
    Acta Oncol; 1996 Mar; 35 Suppl 6():57-71. PubMed ID: 9154086
    [Abstract] [Full Text] [Related]

  • 6. Assessing the economic burden of breast cancer in a US managed care population.
    Barron JJ, Quimbo R, Nikam PT, Amonkar MM.
    Breast Cancer Res Treat; 2008 May; 109(2):367-77. PubMed ID: 17674201
    [Abstract] [Full Text] [Related]

  • 7. Incidence-based cost-of-illness model for metastatic breast cancer in the United States.
    Sorensen SV, Goh JW, Pan F, Chen C, Yardley D, Martín M, Knopf K, Benedict A, Giorgetti C, Iyer S.
    Int J Technol Assess Health Care; 2012 Jan; 28(1):12-21. PubMed ID: 22617734
    [Abstract] [Full Text] [Related]

  • 8. The economic consequences of asthma among adults in Sweden.
    Jansson SA, Rönmark E, Forsberg B, Löfgren C, Lindberg A, Lundbäck B.
    Respir Med; 2007 Nov; 101(11):2263-70. PubMed ID: 17689234
    [Abstract] [Full Text] [Related]

  • 9. Prostate cancer--prevalence-based healthcare costs.
    Norlund A, Alvegård T, Lithman T, Merlo J, Noreen D.
    Scand J Urol Nephrol; 2003 Nov; 37(5):371-5. PubMed ID: 14594683
    [Abstract] [Full Text] [Related]

  • 10. Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy.
    Malmberg I, Persson U, Ask A, Tennvall J, Abrahamsson PA.
    Urology; 1997 Nov; 50(5):747-53. PubMed ID: 9372886
    [Abstract] [Full Text] [Related]

  • 11. [Advanced breast cancer: an evaluation of the cost of recurrence].
    Bercez C, Lebrun T, Bonneterre ME, Selke B, Lenne X, Bonneterre J.
    Bull Cancer; 1999 Jun; 86(6):585-90. PubMed ID: 10417432
    [Abstract] [Full Text] [Related]

  • 12. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.
    Lindblom B, Nordmann JP, Sellem E, Chen E, Gold R, Polland W, Williamson W, Buchholz P, Walt JG, Groleau D, Curry A, Evans SJ.
    Acta Ophthalmol Scand; 2006 Feb; 84(1):74-83. PubMed ID: 16445443
    [Abstract] [Full Text] [Related]

  • 13. Costs in primary care of investigating symptoms suspicious of cancer in a defined population.
    Månsson J, Marklund B, Carlsson P.
    Scand J Prim Health Care; 2006 Dec; 24(4):243-50. PubMed ID: 17118865
    [Abstract] [Full Text] [Related]

  • 14. Direct and indirect costs in a prospective cohort of patients with pancreatic cancer.
    Müller-Nordhorn J, Brüggenjürgen B, Böhmig M, Selim D, Reich A, Noesselt L, Roll S, Wiedenmann B, Willich SN.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):405-15. PubMed ID: 16128678
    [Abstract] [Full Text] [Related]

  • 15. The impact of flare on disease costs of patients with systemic lupus erythematosus.
    Zhu TY, Tam LS, Lee VW, Lee KK, Li EK.
    Arthritis Rheum; 2009 Sep 15; 61(9):1159-67. PubMed ID: 19714597
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diabetes: the cost of illness in Sweden.
    Henriksson F, Jönsson B.
    J Intern Med; 1998 Dec 15; 244(6):461-8. PubMed ID: 9893099
    [Abstract] [Full Text] [Related]

  • 18. Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.
    Ringborg A, Martinell M, Stålhammar J, Yin DD, Lindgren P.
    Int J Clin Pract; 2008 May 15; 62(5):708-16. PubMed ID: 18355236
    [Abstract] [Full Text] [Related]

  • 19. Rheumatoid arthritis: what does it cost and what factors are driving those costs? Results of a survey in a community-derived population in Malmö, Sweden.
    Jacobsson LT, Lindroth Y, Marsal L, Juran E, Bergström U, Kobelt G.
    Scand J Rheumatol; 2007 May 15; 36(3):179-83. PubMed ID: 17657670
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.